Di Tonno, D.; Martena, L.; Taurisano, M.; Perlin, C.; Loiacono, A.C.; Lagravinese, S.; Marsigliante, S.; Maffia, M.; Esposito, S.; Villa, G.;
et al. The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies. Epidemiologia 2024, 5, 137-145.
https://doi.org/10.3390/epidemiologia5010009
AMA Style
Di Tonno D, Martena L, Taurisano M, Perlin C, Loiacono AC, Lagravinese S, Marsigliante S, Maffia M, Esposito S, Villa G,
et al. The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies. Epidemiologia. 2024; 5(1):137-145.
https://doi.org/10.3390/epidemiologia5010009
Chicago/Turabian Style
Di Tonno, Davide, Laura Martena, Manuela Taurisano, Caterina Perlin, Anna Chiara Loiacono, Stefano Lagravinese, Santo Marsigliante, Michele Maffia, Susanna Esposito, Gianluca Villa,
and et al. 2024. "The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies" Epidemiologia 5, no. 1: 137-145.
https://doi.org/10.3390/epidemiologia5010009
APA Style
Di Tonno, D., Martena, L., Taurisano, M., Perlin, C., Loiacono, A. C., Lagravinese, S., Marsigliante, S., Maffia, M., Esposito, S., Villa, G., Gori, G., Bray, L., Distante, A., Miani, A., Piscitelli, P., & Argentiero, A.
(2024). The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies. Epidemiologia, 5(1), 137-145.
https://doi.org/10.3390/epidemiologia5010009
